SCHEMBL9542804

SCHEMBL9542804

C=C1C[C@@]2(C)[C@@H](CCC2(C)O)[C@@H]2CCC3=C(C)C(=O)CC[C@]3(C)[C@H]12

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.50
SHBG P04278 3/20 0.48
ALDH1A1 P00352 2/20 0.41
NR3C1 P04150 1/20 0.41
PGR P06401 1/20 0.41
ADRA1A P35348 1/20 0.41
HTR2B P41595 1/20 0.41
TSHR P16473 1/20 0.39
THPO P40225 1/20 0.39
HIF1A Q16665 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP19A1 P11511 12/20 0.39
POLB P06746 1/20 0.37
MAPK1 P28482 1/20 0.37
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9541188 1.00 CYP3A4 (0.50) CYP3A4SHBGALDH1A1NR3C1PGR
SCHEMBL9543824 0.84 SHBG (0.35) CYP3A4SHBGALDH1A1NR3C1PGR
SCHEMBL9542574 0.81 CYP3A4 (0.67) CYP3A4SHBGALDH1A1NR3C1PGR
SCHEMBL9542566 0.81 CYP3A4 (0.67) CYP3A4SHBGALDH1A1NR3C1PGR
SCHEMBL9541306 0.80 SHBG (0.33) CYP3A4SHBGALDH1A1NR3C1PGR
SCHEMBL9542925 0.80 SHBG (0.33) CYP3A4SHBGALDH1A1NR3C1PGR
SCHEMBL9541167 0.78 CYP19A1 (0.40) CYP3A4SHBGALDH1A1NR3C1PGR
SCHEMBL9541172 0.78 CYP19A1 (0.40) CYP3A4SHBGALDH1A1NR3C1PGR
SCHEMBL9125266 0.77 NR3C1 (0.67) CYP3A4SHBGALDH1A1NR3C1PGR
SCHEMBL9125273 0.77 NR3C1 (0.67) CYP3A4SHBGALDH1A1NR3C1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993013122-A1 3-METHYLSULPHONYLHYDRAZONO AND 3-OXYIMINO STEROIDS, A METHOD OF PREPARING THEM, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF DRUGS SCHERING AKTIENGESELLSCHAFT (DE) 1993-07-08 WO disclosed